Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EHA 2018: Molecular profiling in multiple myeloma 

Written by | 3 Aug 2018

In addition to clinical segmentation of MM patients as young or elderly and fit or frail, genetic factors convey important prognostic information and should be taken into account… read more.

Vulnerable patients: burning questions in IBD

Written by | 30 Mar 2017

An interesting session at ECCO dealt with the patients for whom there is sparce data to guide their treatment – experts in the field gave their guidance to… read more.

Duloxetine shows efficacy for pain associated with breast cancer treatment

Written by | 19 Dec 2016

By Bruce Sylvester Duloxetine (Cymbalta ®), a widely-used treatment for depression and anxiety, appears to reduce joint pain in postmenopausal women being treated for early stage breast cancer,… read more.

Cancer survival worse in RA patients

Written by | 19 Aug 2016

Survival was more than 2 years shorter in breast, prostate cancers.  Patients with rheumatoid arthritis (RA) had a 40% to 50% increased mortality risk if they developed breast… read more.

Less painkilling medication with breast-cancer surgery after opiate-free anesthesia

Written by | 12 Aug 2016

New research presented at Euroanaesthesia 2016 (London 27-30 May) shows that patients undergoing breast cancer surgery need less painkilling medication post-surgery if they have anaesthesia that is free… read more.

World Health Matters: Italy – 3D screening detects more cancers in dense breast tissue

Written by | 25 May 2016

by Gary Finnegan: Researchers have found that in over 3,000 Italian women with dense breasts where standard mammograms had not detected any cancer, the addition of tomosynthesis (a… read more.

Herceptin plus lapatinib shows “amazing” potential in breast cancer

Written by | 3 May 2016

by Bruce Sylvester: Researchers report that Herceptin (trastuzamab) plus lapatinib can shrink breast cancer tumors in less than two weeks. The findings were reported in March at the… read more.

World Health Matters: Italy: Leukaemia death rate expected to fall in 2016

Written by | 22 Feb 2016

by Gary Finnegan: Good news in the battle against cancer: death rates from leukaemia among people of all ages in Europe are falling.

Anastrozole is effective for treating early form of breast cancer

Written by | 24 Dec 2015

by Bruce Sylvester: Anastrozole appears to be as effective as tamoxifen in treating ductal carcinoma in situ (DCIS), a very early form of breast cancer, and could offer… read more.

ESOT 2015: Tailor-made immunosuppression and post-transplant follow-up

Written by | 19 Nov 2015

by Maria Dalby: Advances in diagnostic techniques, genetic testing and immunosuppressive protocols allow clinicians to tailor interventions to the individual patient’s needs to a greater extent than in… read more.

World Health Matters: Exercise helps women tolerate chemotherapy

Written by | 19 Oct 2015

by Gary Finnegan: Netherlands: Women with breast cancer who follow a physical exercise programme during their chemotherapy treatment experience fewer side effects, according a study by the Netherlands… read more.

ICML 2015 Report: Update on the revision of the WHO lymphoma classification

Written by | 28 Jul 2015

Steven H Swerdlow, University of Pittsburgh Medical Center, USA, / by Maria Dalby.  Knowledge is evolving fast in the field of lymphoma and the 2008 World Health Organization… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.